Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
Canada’s Trade Deficit Jumps in November as Exports Slide and Firms Diversify Away From U.S. 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Gold Prices Pull Back After Record Highs as January Rally Remains Strong 
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions 
Oil Prices Slide Nearly 3% as U.S.-Iran Talks Ease Geopolitical Tensions 
UK Employers Plan Moderate Pay Rises as Inflation Pressures Ease but Persist 
Dollar Holds Firm as Markets Weigh Warsh-Led Fed and Yen Weakness Ahead of Japan Election 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
California start-up Bionaut Labs will conduct its first clinical trials on sending miniature robots deep inside the human skull to treat brain disorders
The tiny injectable robots can be guided through the brain using magnets.
Micro-robot technology "that used to be science fantasy in the 1950s and 1960s" is now "scientific fact," according to Michael Shpigelmacher, Bionaut Labs' founder and CEO.
Working with Germany's famed Max Planck research institutes, Bionaut Labs chose magnetic energy over optical or ultrasonic means to propel the robots because it is non-harmful to the human body.
Magnetic coils implanted outside the patient's skull are connected to a computer that can remotely and delicately navigate the micro-robot into the damaged area of the brain before withdrawing it the same way.
Unlike an MRI, the entire system is portable and utilizes 10 to 100 times less electricity.
The robot, which is a metal cylinder just a few millimeters long and shaped like a small bullet, follows a pre-programmed trajectory through a gel-filled container that mimics the density of the human brain in a simulation observed by AFP.
When the robot gets close enough to a pouch filled with blue liquid, it accelerates like a rocket and pierces the sack with its pointed end, allowing liquid to gush out.
When clinical trials begin in two years, the inventors want to use the robot to penetrate fluid-filled cysts in the brain.
The method could be used to cure Dandy-Walker Syndrome, a rare brain abnormality that affects youngsters if it is successful.
Cysts the size of a golf ball can form in congenital illness sufferers, swelling and increased pressure on the brain, initiating a slew of serious neurological problems.
Bionaut Labs has already tested its robots on large animals like lambs and pigs, and according to Shpigelmacher, "the evidence suggests that the technology is safe for us."
If approved, the robots could provide significant benefits over currently available therapies for brain illnesses.
Last year, the US Food and Drug Administration (FDA) awarded Bionaut Labs clearance to begin clinical studies for Dandy-Walker Syndrome and malignant gliomas, which are cancerous brain tumors that are frequently considered inoperable.
The micro-robots will be used to inject anti-cancer medications directly into brain tumors in a "surgical strike" in cancerous brain tumors.
